{{Rsnum
|rsid=805297
|Gene=APOM
|Chromosome=6
|position=31654829
|Orientation=minus
|GMAF=0.2759
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=APOM,BAG6
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 46.9 | 44.2 | 8.8
| HCB | 51.8 | 36.5 | 11.7
| JPT | 30.1 | 47.8 | 22.1
| YRI | 100.0 | 0.0 | 0.0
| ASW | 87.7 | 12.3 | 0.0
| CHB | 51.8 | 36.5 | 11.7
| CHD | 45.0 | 45.0 | 10.1
| GIH | 53.5 | 40.6 | 5.9
| LWK | 98.2 | 1.8 | 0.0
| MEX | 25.9 | 56.9 | 17.2
| MKK | 91.0 | 9.0 | 0.0
| TSI | 35.3 | 52.9 | 11.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=21844665
|Title=Common variants at the promoter region of the APOM confer a risk of rheumatoid arthritis
|OA=1
}}

{{PMID|21390319|OA=1
}} Apolipoprotein M gene (APOM) polymorphism modifies metabolic and disease traits in type 2 diabetes. C allele of rs805297 was significantly associated with T2D duration of longer than 10 years (OR?=?1.245, p?=?0.015). 

{{PMID Auto
|PMID=22685595
|Title=Genotype-Based Test in Mapping Cis-Regulatory Variants from Allele-Specific Expression Data
|OA=1
}}

{{PMID Auto
|PMID=23660425
|Title=Apolipoprotein m (APOM) levels and APOM rs805297 G/T polymorphism are associated with increased risk of rheumatoid arthritis
}}

{{PMID Auto
|PMID=24341666
|Title=A single-nucleotide polymorphism in the proximal promoter region of the apolipoprotein M gene is associated with dyslipidaemia but not increased coronary artery diseases in Chinese populations
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}